Short report: smoking habits and the acquisition of metronidazole resistance in patients with Helicobacter pylori‐related gastritis
- 1 December 1993
- journal article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 7 (6) , 683-687
- https://doi.org/10.1111/j.1365-2036.1993.tb00151.x
Abstract
Thirty-three dyspeptic patients with colonization of Helicobacter pylori in the gastric antrum were treated with tripotassium dicitrate bismuthate 120 mg q.d.s. for 28 days and metronidazole 250 mg q.d.s. for 10 days starting on day 19. Five weeks after cessation of this treatment regimen H. pylori was eradicated in 23 patients. In 8 of the remaining 10 patients, H. pylori had become resistant to metronidazole. In this study resistance was significantly associated with smoking habits, but not with age, bacterial load, gastritis score or alcohol consumption.Keywords
This publication has 14 references indexed in Scilit:
- Experience with‘triple’ anti‐Helicobacter pylori eradication therapy: side effects and the importance of testing the pre‐treatment bacterial isolate for metronidazole resistanceAlimentary Pharmacology & Therapeutics, 1992
- Reduced transcription of the ferredoxin gene in metronidazole-resistant Trichomonas vaginalis.Proceedings of the National Academy of Sciences, 1992
- DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and suodenumGastroenterology, 1992
- Factors influencing the eradication of Helicobacter pylori with triple therapyGastroenterology, 1992
- Proposed mechanism for metronidazole resistance in Helicobacter pyloriJournal of Antimicrobial Chemotherapy, 1992
- Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.BMJ, 1991
- Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.Gut, 1990
- Metronidazole-resistant Helicobacter pyloriThe Lancet, 1990
- PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORIThe Lancet, 1988
- Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.Journal of Clinical Pathology, 1988